Related Experiment Video
Updated: Jan 19, 2026
08:52
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
4.6K
Perspective: Cellular and Molecular Profiling Technologies in Personalized Oncology.
1International Iberian Nanotechnology Laboratory, 4715-330 Braga, Portugal. andrea.cruz@inl.int.
Journal of Personalized Medicine
|September 25, 2019
Summary
Technological innovations, including biomarker-based tests, are enabling decentralized cancer care and self-monitoring. This progress moves us closer to personalized oncology, improving public health outcomes.
Area of Science:
- Oncology
- Biotechnology
- Public Health
Background:
- Cancer remains a significant global health challenge, driving the need for advanced diagnostic and monitoring solutions.
- Current healthcare models often require centralized facilities, limiting accessibility and timely intervention.
Purpose of the Study:
- To review key technological innovations in cancer care.
- To explore the potential of these technologies for decentralization and personalized oncology.
Main Methods:
- Discussion of recent technological advancements.
- Analysis of biomarker-based technologies.
- Evaluation of point-of-care technologies.
Main Results:
- Key enabling technologies are emerging, including biomarker-based approaches.
- Decentralization of cancer monitoring, such as self-monitoring, is becoming feasible.
- Point-of-care technologies are increasingly available.
Conclusions:
- Technological innovations are crucial for advancing personalized oncology.
- Decentralized approaches promise to enhance cancer care accessibility and efficiency.
- The integration of these technologies marks a significant step toward tailored cancer treatment strategies.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:18Cancer
53.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.5K